Xinjiang Bai Hua Cun Pharma TechLtd Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Hui Huang
Chief executive officer
CN¥1.3m
Total compensation
CEO salary percentage | n/a |
CEO tenure | 4.1yrs |
CEO ownership | 0.1% |
Management average tenure | no data |
Board average tenure | 4.7yrs |
Recent management updates
Recent updates
Shareholders Can Be Confident That Xinjiang Bai Hua Cun Pharma TechLtd's (SHSE:600721) Earnings Are High Quality
Nov 01The Price Is Right For Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd (SHSE:600721) Even After Diving 26%
Sep 04Investors Still Waiting For A Pull Back In Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd (SHSE:600721)
Jun 22We Think Xinjiang Bai Hua Cun Pharma TechLtd's (SHSE:600721) Profit Is Only A Baseline For What They Can Achieve
May 02Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd's (SHSE:600721) P/S Is Still On The Mark Following 34% Share Price Bounce
Mar 08CEO
Hui Huang (40 yo)
4.1yrs
Tenure
CN¥1,296,900
Compensation
Mr. Hui Huang serves as Rotating General Manager and Director at Xinjiang Bai Hua Cun Pharam Tech Co.,Ltd (formerly known as Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd (formerly known as Xinjiang Baihuacun C...
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Rotating GM & Director | 4.1yrs | CN¥1.30m | 0.11% CN¥ 2.8m | |
CFO, Secretary & Director | 1.8yrs | CN¥529.90k | 0.051% CN¥ 1.3m | |
Executive Deputy GM & Director | 7.1yrs | CN¥760.00k | 0.051% CN¥ 1.3m | |
Deputy GM & Director | 3.3yrs | CN¥1.07m | 0.061% CN¥ 1.5m | |
Independent Director | 1.1yrs | CN¥5.60k | no data | |
Chairman | 7.3yrs | CN¥879.90k | no data | |
Independent Director | 6.4yrs | CN¥80.00k | no data | |
Director | 5.3yrs | no data | no data | |
Independent Director | 3.3yrs | CN¥80.00k | no data | |
Chairman of the Supervisory Board | 5.3yrs | no data | no data | |
Supervisor | 5.3yrs | no data | no data | |
Employee Supervisor | 3.3yrs | no data | no data |
4.7yrs
Average Tenure
54.5yo
Average Age
Experienced Board: 600721's board of directors are considered experienced (4.7 years average tenure).
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/01/29 21:36 |
End of Day Share Price | 2025/01/27 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Shuchang Liu | Changjiang Securities Co. LTD. |